NCT00537043View on ClinicalTrials.gov

A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Hypertension

Interventions

DRUG

SK&F-105517 (COREG CR FDC)

Trial Locations (2)

78704

GSK Investigational Site, Austin

07601

GSK Investigational Site, Hackensack

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY